- Home
- ARQT vs RRR Comparison
ARQT vs RRR Comparison
Compare ARQT & RRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | RRR |
|---|---|---|
| Founded | 2016 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ARQT | RRR |
|---|---|---|
| Price | $22.18 | $57.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $34.00 | ★ $66.46 |
| AVG Volume (30 Days) | ★ 1.2M | 746.6K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | ★ 88.79 | 23.32 |
| EPS | N/A | ★ 3.12 |
| Revenue | $376,072,000.00 | ★ $2,011,483,000.00 |
| Revenue This Year | $34.46 | $3.26 |
| Revenue Next Year | $29.77 | $4.48 |
| P/E Ratio | ★ N/A | $19.20 |
| Revenue Growth | ★ 91.34 | 3.74 |
| 52 Week Low | $11.86 | $35.09 |
| 52 Week High | $31.77 | $68.99 |
Technical Indicators
Market Signals| Indicator | ARQT | RRR |
|---|---|---|
| Relative Strength Index (RSI) | 37.45 | 39.98 |
| Support Level | $22.56 | $55.56 |
| Resistance Level | $27.26 | $61.64 |
| Average True Range (ATR) | 0.92 | 2.02 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 22.56 | 26.59 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.